Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q89VE8

Entry ID Method Resolution Chain Position Source
AF-Q89VE8-F1 Predicted AlphaFoldDB

No variants for Q89VE8

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q89VE8

No associated diseases with Q89VE8

2 regional properties for Q89VE8

Type Name Position InterPro Accession
domain Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain 152 - 302 IPR006131
domain Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding 6 - 146 IPR006132

Functions

Description
EC Number 2.1.3.3 Carboxy- and carbamoyltransferases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
amino acid binding Binding to an amino acid, organic acids containing one or more amino substituents.
ornithine carbamoyltransferase activity Catalysis of the reaction: carbamoyl phosphate + L-ornithine = phosphate + L-citrulline.

2 GO annotations of biological process

Name Definition
arginine biosynthetic process via ornithine The chemical reactions and pathways resulting in the formation of arginine (2-amino-5-guanidinopentanoic acid) via the intermediate compound ornithine.
citrulline biosynthetic process The chemical reactions and pathways resulting in the formation of citrulline, N5-carbamoyl-L-ornithine, an alpha amino acid not found in proteins.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSKSPKHFLD INELPLSELK SMLDASSAMK AKQKAHQPVR PLEGKTLAMI FERPSTRTRV
70 80 90 100 110 120
SFDVAMRQLG GEPIMLTGAE MQLGRGETIA DTARVLSRYV DAIMIRILNH DALLELAANA
130 140 150 160 170 180
TVPVINGLTR RSHPCQVMAD LLTYQEHRGP IEGRTVAWTG DDNNVLASWA HAAERFKFQL
190 200 210 220 230 240
NVATPPELAP KKAMRDWIKA SGAPIMLGTD PEAAVRGADC VVTDTWVSMG DKEGEHRHNV
250 260 270 280 290 300
LKPYQVNAKL MSLAKPDALF MHCLPAHRGE EVTDEVIDGP QSVVFDEAEN RLHAQKGILA
WCFDAVK